Upregulation of p27 and its inhibition of CDK2/cyclin E activity following DNA damage by a novel platinum agent are dependent on the expression of p21
Authors:
Open Access
- 7 November 2006
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 95 (11) , 1514-1524
Abstract
The cisplatin analogue 1R,2R-diaminocyclohexane(trans-diacetato)(dichloro)platinumIV (DAP) is a DNA-damaging agent that will be entering clinical trials for its potent cytotoxic effects against cisplatin-resistant tumour cells. This cytotoxicity may reside in its ability to selectively activate G1-phase checkpoint response by inhibiting CDKs via the p53/p21 pathway. We have now evaluated the role of another CDK inhibitor p27 as a contributor to DAP-mediated inhibition of G1-phase CDK2 activity. Our studies in ovarian A2780 tumour cells demonstrate that p27 levels induced by DAP are comparable to or greater than those seen for p21. The induction of p27 is not through a transcriptional mechanism, but rather is due to a four-fold increase in protein stabilisation through a mechanism dependent on p21. Moreover, DAP-induced p21 promoted the selective increase of p27 in the CDK2 complex, but not in CDK4 complex, and this selective increase contributed to inhibition of the CDK2 kinase activity. The inhibited complex contained either p27 or p21, but not both, with the relative levels of cyclin E associated with p27 and p21 indicating that about 25% of the inhibition of CDK2 activity was due to p27 and 75% due to p21. This study provides the first evidence that p27 upregulation is directly attributable to activation of the p53/p21 pathway by a DNA-damaging agent, and promulgates p53/p21/p27 axis as a significant component of checkpoint response.Keywords
This publication has 50 references indexed in Scilit:
- RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cellsOncogene, 2005
- UCN-01-Induced Cell Cycle Arrest Requires the Transcriptional Induction of p21waf1/cip1 by Activation of Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase/Extracellular Signal-Regulated Kinase PathwayCancer Research, 2004
- Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agentsJournal of Cancer Research and Clinical Oncology, 2003
- Spy1 Interacts with p27Kip1 to Allow G1/S ProgressionMolecular Biology of the Cell, 2003
- Cell cycle-independent upregulation of p27Kip1 by p21Waf1 in K562 cellsOncogene, 2001
- UVB induced cell cycle checkpoints in an early stage human melanoma line, WM35Oncogene, 2000
- Mechanism of Cdk2/Cyclin E Inhibition by p27 and p27 PhosphorylationBiochemistry, 1999
- Induction of p21CIP1/Waf1and Activation of p34cdc2Involved in Retinoic Acid-Induced Apoptosis in Human Hepatoma Hep3B CellsExperimental Cell Research, 1999
- Activation of telomerase and its association with G1-phase of the cell cycle during UVB-induced skin tumorigenesis in SKH-1 hairless mouseOncogene, 1999
- Changes in Cyclins and Cyclin-Dependent Kinases Induced by DNA Damaging Agents in a Human Ovarian Cancer Cell Line Expressing Mutated or Wild-Type P53Experimental Cell Research, 1996